FIELD: medicine.
SUBSTANCE: method enables predicting clinical effectiveness of the human chorionic gonadotropin therapy of hypogonadotropic and normogonadotropic hypogonadism depending on the blood testosterone and oestradiol levels following a three-day human chorionic gonadotropin test; if observing the oestradiol level more than 1.5 times higher, the prescribed human chorionic gonadotropin therapy is considered to be inadequate.
EFFECT: higher clinical effectiveness.
2 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTION OF CLINICAL EFFECTIVENESS OF TREATMENT WITH CHORIONIC GONADOTROPIN IN MALES WITH HYPOGONADISM | 2015 |
|
RU2604681C1 |
METHOD FOR PREDICTING SPERMATOGENESIS STIMULATION EFFECTIVENESS IN OLIGOSPERMIC INFERTILITY (SECRETORY OLYGO- AND AZOOSPERMIA) CASES | 2004 |
|
RU2302641C2 |
METHOD FOR INTEGRATED TREATMENT OF MALE NORMOGONADOTROPIC INFERTILITY | 2012 |
|
RU2480256C1 |
METHOD OF TREATING RELATIVE STERILITY IN VARICOCELE | 2010 |
|
RU2419453C1 |
METHOD OF TREATING HYPOGONADOTROPIC HYPOGONADISM, NASAL SPRAY AS METHOD FOR ADMINISTERING GONADORELIN ACETATE IN TREATING HYPOGONADOTROPIC HYPOGONADISM | 2019 |
|
RU2733465C1 |
METHOD OF TREATING OBSTRUCTIVE AZOOSPERMIA AND CRYPTOZOOSPERMIA IN PATIENTS WITH CHRONIC PROSTATITIS | 2015 |
|
RU2586305C1 |
DIAGNOSTIC TECHNIQUE FOR HORMONAL DISORDERS IN MEN | 2019 |
|
RU2715565C1 |
METHOD OF AGE-SPECIFIC THERAPY AND PREVENTION OF CONNECTIVE TISSUE DYSPLASIA | 2016 |
|
RU2657751C1 |
METHOD FOR CORRECTION OF HYPERESTRADIOLEMIA AND NORMOGONADOTROPIC HYPOGONADISM IN MALES | 2010 |
|
RU2474424C2 |
METHOD FOR TREATMENT OF ADOLESCENT HYPOGONADOTROPIC HYPOGONADISM IN EXPERIMENT | 2020 |
|
RU2750713C1 |
Authors
Dates
2014-06-20—Published
2012-12-06—Filed